Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fractyl Health (GUTS) Net Income towards Common Stockholders (2023 - 2025)

Fractyl Health's Net Income towards Common Stockholders history spans 3 years, with the latest figure at -$43.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Net Income towards Common Stockholders fell 75.12% year-over-year to -$43.7 million, compared with a TTM value of -$141.0 million through Dec 2025, down 100.13%, and an annual FY2025 reading of -$141.0 million, down 100.13% over the prior year.
  • Net Income towards Common Stockholders for Q4 2025 was -$43.7 million at Fractyl Health, up from -$45.6 million in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was -$5.1 million in Q1 2024, with the low at -$45.6 million in Q3 2025.
  • Average Net Income towards Common Stockholders over 3 years is -$25.5 million, with a median of -$23.6 million recorded in 2023.
  • Year-over-year, Net Income towards Common Stockholders soared 68.71% in 2024 and then crashed 369.16% in 2025.
  • Tracing GUTS's Net Income towards Common Stockholders over 3 years: stood at -$23.5 million in 2023, then dropped by 6.21% to -$25.0 million in 2024, then tumbled by 75.12% to -$43.7 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Net Income towards Common Stockholders are -$43.7 million (Q4 2025), -$45.6 million (Q3 2025), and -$27.9 million (Q2 2025).